Results 161 to 170 of about 3,057,322 (296)
Synthesis of Azulene Derivatives from Troponoids and Cyanoacetic Ester
, 1956 Tetsuo Nozoe +3 more
openalex +2 more sources
XXI.—The synthetical formation of closed carbon-chains. Part V. Experiments on the synthesis of heptamethylene-derivatives [PDF]
, 1888 Paul C. Freer, W. H. Perkin
openalex +1 more source
Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients
Molecular Oncology, EarlyView.Small cell lung cancer (SCLC) is an aggressive form of lung cancer that spreads rapidly to secondary sites such as the brain and liver. Cancer cells circulating in the blood, “circulating tumor cells” (CTCs), have demonstrated prognostic value in SCLC, and evaluating biomarkers on CTCs could guide treatment decisions such as for PARP inhibitors ...
Prajwol Shrestha +6 more
wiley +1 more source
Infection and Drug Resistance, 2018 Pan-Pan Wu,1–3 Hao He,1,3 W David Hong,1,3–5 Tong-Rong Wu,1,3 Gui-Ying Huang,2 Ying-Ying Zhong,2 Bo-Rong Tu,1,3 Min Gao,1,3 Jun Zhou,1,3 Su-Qing Zhao,1–3 Dong-Li Li,1,3 Xue-Tao Xu,1,3 Zhao-Jun Sheng,1,3 Stephen A Ward,4 Paul M O&rsquo ...
Wu PP +15 more
doaj
LXXVIII.—The action of tribromopropane ón the sodium derivative of ethyl acetoacetate [PDF]
, 1907 Thomas Edward Gardner, W. H. Perkin
openalex +1 more source
A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer
Molecular Oncology, EarlyView.Lung cancer cells were spiked into donor blood to evaluate the recovery rates of the following circulating tumor cell (CTC) enrichment technologies: CellMag™, EasySep™, RosetteSep™, Parsortix® PR1, and Parsortix® Prototype systems. Each method's advantages and disadvantages are described.
Volga M Saini +11 more
wiley +1 more source
Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors
Molecular Oncology, EarlyView.Cell‐free microRNAs (cfmiRs) are small‐RNA circulating molecules detectable in almost all body biofluids. Innovative technologies have improved the application of cfmiRs to oncology, with a focus on clinical needs for different solid tumors, but with emphasis on diagnosis, prognosis, cancer recurrence, as well as treatment monitoring.
Yoshinori Hayashi +6 more
wiley +1 more source
Molecular Oncology, EarlyView.This study demonstrates that KRAS and GNAS mutations are more prevalent in patients with resected intraductal papillary mucinous neoplasms (IPMN) compared to those under clinical surveillance. GNAS mutations significantly differ between the two patient cohorts, indicating that their absence may serve as a potential biomarker to support conservative ...
Christine Nitschke +12 more
wiley +1 more source